Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Urovant Sciences Gmbh

Clinical trials sponsored by Urovant Sciences Gmbh, explained in plain language.

Now part of Sumitomo Pharma Co., Ltd. 4506 TOKYO

A specialty pharmaceutical company focused on urology treatments, subsidiary of Sumitomo Pharma.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Daily pill aims to improve bladder function in children with spinal conditions

Disease control Recruiting now

This study tests a daily pill called vibegron to see if it safely improves bladder control in children aged 2 to 18 with neurogenic detrusor overactivity (NDO), a condition where the bladder contracts too often due to nerve damage. Participants must already use a catheter to empt…

Phase: PHASE2, PHASE3 • Sponsor: Urovant Sciences GmbH • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC